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Males and females differ widely in morphology, physiology, and behavior leading to disparities in many health
outcomes, including sex biases in the prevalence of many neurodevelopmental disorders. However, with the
exception of a relatively small number of genes on the Y chromosome, males and females share a common
genome. Therefore, sexual differentiation must in large part be a product of the sex biased expression of this
shared genetic substrate. microRNAs (miRs) are small non-coding RNAs involved in the post-transcriptional
regulation of up to 70% of protein-coding genes. The ability of miRs to regulate such a vast amount of the
genome with a high degree of specificity makes them perfectly poised to play a critical role in programming of the
sexually dimorphic brain. This review describes those characteristics of miRs that make them particularly amenable
to this task, and examines the influences of both the sex chromosome complement as well as gonadal hormones
on their regulation. Exploring miRs in the context of sex differences in disease, particularly in sex-biased
neurodevelopmental disorders, may provide novel insight into the pathophysiology and potential therapeutic
targets in disease treatment and prevention.
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Introduction
A decade of genome-wide association studies has identi-
fied numerous genetic loci associated with neurodeve-
lopmental disorder susceptibility. While statistically
significant, the effect size of individual loci has tended to
be quite small. In contrast, the presence of either a Y or
a second X chromosome is likely one of the strongest
genetic predictors of many aspects of neurodevelopmen-
tal disorders, including prevalence, presentation, and
therapeutic outcome. Sex differences in health outcomes
are not limited to neurodevelopmental disease; instead,
the importance of sex has been highlighted in immune-
related diseases, many cancers, and coronary heart dis-
ease as examples [1-3]. Recognition of these sex-biases
in disease is leading to investigation of the underlying
molecular processes responsible for sexual differenti-
ation of cells and tissues.
It is becoming clear that the complexity of gene ex-
pression responses, or the conversion of information* Correspondence: tbale@vet.upenn.edu
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distribution, and reproduction in any mediumcontained in a genetic element into a molecular effector,
results from regulatory mechanisms beyond the simple
interactions of transcription factors and DNA cis-
regulatory sequences. Instead, appropriate regulation of
gene expression results from a controlled balance be-
tween transcriptional and post-transcriptional mechan-
isms. With this in mind, we have begun to examine
microRNAs (miRs) in the context of sex differences.
miRs are essential for both the development and adult
function of all tissues, and the dysregulation of miR expres-
sion has been linked to a variety of human diseases, such as
cancer, immune dysfunction, metabolic, and cardiovascular
diseases [2,4-7]. Recent studies have begun identifying sex
differences and specificity in miR responses to pathologic
conditions, such as cerebral ischemia and radiation, and in
cancers including hepatocellular and squamous cell carcin-
omas [1,8-10]. In addition, recent work in our own
lab has implicated the developmental miR environ-
ment in the sexual differentiation of the brain [11]. As such,
the disruption of normal miR expression patterns could be
a potential risk factor in neurodevelopmental disease, con-
tributing to the sex-biases found in these disorders. In this
review, we will highlight characteristics of miRs that makentral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly cited.
Table 1 Common molecules in microRNA biogenesis and function
Molecule Function Reference
Primary microRNA (pri-miR)‘ Initial transcription from independent (not intronic) miR gene results in a pri-miR, A pri-miR is often
multiple kilobases in length and may encode more then one mature miRNA.
[12]
Pre-microRNA (pre-miR) Processing of pri-miR by microprocessor results in pre-miR. PremiRs are 60–70 bp double stranded
RNAs with intramolecular sequence complementarity, so that they form stem-loop structures.
[20]
microRNA (miR) Mature single stranded RNA 20–22 bp in length. Exists in complex w ith Argonaute and accessory
proteins as part of the RISC complex, providing target specificity.
[20]
Mirtron miRs located within introns of protein coding genes, Transcribed as part of their host genes
primary transcript, but are cleaved from this during mRNA splicing, resulting in a pre-miR.
[15]
Microprocessor complex Multi-protein complex, containing the obligate members Drosha and DGCR8. Responsible for
cleaving stem-loop structures from pn-miR, resulting in pre-miRNA.
[52]
Drosha RNase III protein. One of two obligate members of the microprocessor complex. [73]
DGCR8 Double stranded RNA binding domain protein. One of two obligate members of the
microprocessor complex.
[73]
Dicer RNase Ill-like protein. Cleaves ‘loops of stem-loop from pre-miR, resulting in a 20–22 bp miRNA
duplex. Assists in loading one strand of this duplex, the guide strand, into RISC complex.
[12]
RISC RNA induced silencing complex (RISC) is a multi-protein complex containing Argo bound to a
single stranded miR. Association of the RISC complex with a mRNA target leads to
mRNAdestabilization/degradation, either through direct RNase actions of Argo II or the activity
of other recruited accessory proteins.
[74]
Argonaute (Argo) Component of the RISC complex, it acts at the interface between a miR and mRNA target. There
are four mammalian Argonautes, though only Argo II has RNase activity.
[16] [74]
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ation of the brain, and discuss mechanisms through which
sex biased miR expression can occur.
microRNA: biogenesis and activity
miRs are small non-coding RNAs that regulate post-
transcriptional gene expression by affecting the stability or
translational efficiency of specific mRNA targets. The ma-
jority of miRs are organized in clusters within the genome,
and are co-transcribed as single long poly-cistronic primary
transcripts (pri-miRs) that are multiple kilobases in length
(see Table 1) [12]. The transcription of these pri-miRs is
RNA polymerase II dependent, and regulated by the same
mechanisms as mRNAs [13]. Also similar to mRNAs, pri-
miRs undergo 5’ capping and 3’ polyadenylation [14]. Por-
tions of the pri-miR folds back on itself to form a distinct
stem-loop structure (see Figure 1). In the nucleus, a
Drosha-containing microprocessor cleaves the pri-miR at
the base of this ‘stem’, generating a 60–70 bp precursor
(pre)-miR [12]. Other miRs, termed mirtrons, are located
within introns of mRNAs, and are co-transcribed with their
host gene [13,15]. Mirtrons bypass Drosha processing, and
instead use mRNA splicing machinery to generate pre-
miRs [15]. In the cytosol, Dicer processes pre-miRs into
double stranded 22 bp miR duplexes, and assists in loading
one of the strands of a duplex (the guide strand) into the
Argonaute-containing RNA-induced silencing complex
(known as the RISC complex). Argonaute proteins act at
the interface between miRs and their target mRNAs to me-
diate the functional consequences of these interactions [16].There are four different Argonaute proteins found in mam-
mals, Argo 1–4, though 60% of miR-associated RISC com-
plexes contain Argo 2, the only Argonaute with
endonuclease activity [16,17]. Mature miRs guide the RISC
complex to the 3’ UTR of mRNAs, providing target specifi-
city through partial sequence homology, and typically
resulting in mRNA destabilization and degradation [18-20].
Thus, a typical rule is that with an increase in miR expres-
sion, you see a concordant decrease in the target mRNA.
miRs act as major components of an integrated gene
expression regulatory mechanism [21]. One genome-
wide bioinformatics study annotated more than 45,000
conserved miR binding sites in the 3’ UTR of 60% of
human genes [22]. In addition, each miR can directly
target more than a hundred different mRNA targets,
making this mode of regulation far-reaching and capable
of profound programmatic effects [23,24]. For example,
more than 600 distinct mRNA targets were identified by
Argonaute immunoprecipitation following miR-124
overexpression in MCF-7 cells, an immortalized breast
cancer cell line [25]. Interestingly, the presence of a miR
does not necessarily result in the complete absence of
expression of target transcripts. In fact, in two separate
proteomic studies the transfection or deletion of a single
miR (including miR-1, miR-16, miR-30a, miR-155, miR-
124, miR223, or Let-7b) affected the production of hun-
dreds of proteins. However, the magnitude of these
effects on individual proteins was modest (1–2 fold
changes) [23,24]. These data support a model of miR
function proposed by Bartel and Chen, in which they
Figure 1 (See legend on next page.)
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Figure 1 Schematic representation of miRNA (miR) biogenesis. A, Most miRs are transcribed as polycistronic primary-miRs (pri-miRs) by RNA
polymerase II, before undergoing 5' capping and 3' polyadenylation. Portions of the pri-miR folds back on itself to form double-stranded stem-
loop structures. B, The Microprocessor complex cleaves these stem-loops from pri-miRs, generating 50–70 bp pre-miRs with a short 3' overhang.
Drosha and DGCR8 are the obligate components of the Microprocessor complex, though additional accessory proteins, such as the RNA helicases
P68 and P72, can regulate the activity of the complex. C, The short 3' overhang is recognized by components of the nuclear export machinery,
leading to active transport of pre-miRs out into the cytosol. In the cytosol, Dicer acts in complex with accessory proteins to process the pre-miRs
into double stranded 22 bp duplexes. D, Dicer then assists in loading one strand of this duplex, the guide strand, into the Argonaute-containing
RISC complex. E, Mature miRs guide the RISC complex to specific mRNA targets. miRs identify mRNA targets through regions of sequence
homology in the mRNA's 3' UTR. The outcome of this interaction can depend on the degree of sequence complementarity and the specific
Argonaute present in the RISC complex, but destabilization of the mRNA and subsequent degradation is likely.
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“tuning targets” that have taken advantage of the miR
environment and machinery to develop an additional
level of regulation [26]. This provides a cell with a
greater ability to fine-tune gene expression in response
to a continuously changing environment.
Importance of modulators of gene expression in sexual
differentiation
Males and females differ widely in morphology, physi-
ology, and behavior. These differences are the inevitable
product of natural selection acting on a sexually repro-
ducing species. At the most basic level, eggs ‘cost’ more
than sperm. Because of this fundamental sex difference
in parental investment, males and females are under
sex-specific selection pressures, and so are driven to de-
velop phenotypic sex differences [27]. While the poly-
genic nature of most phenotypes complicates the direct
linkage of sexually dimorphic traits to specific genes,
these phenotypes must have a genetic underpinning.
Yet, with the exception of the Y chromosome, male and
female genomes do not vary in sequence, and sexual an-
tagonism may arise in which the expression of a shared
gene is adaptive in one sex, but maladaptive in the other
[28]. This differential selection pressure in the context of
a shared genetic substrate will drive the development of
sex-specific gene expression modifiers [29,30]. miRs
likely play an important, but currently underappreciated
role in these regulatory processes.
Sexual selection acts foremost on the gonad/gameto-
genesis and the development of sex-specific behaviors,
which require differentiation of the brain. Sexual differ-
entiation of neural tissue is the result of the combined
influences of genetic and hormonal differences between
males and females [31,32]. Genetic differences, in the
form of sex chromosome complement, are present from
the time of fertilization, and influence development
throughout life. In addition, the developmental trajectory
and adult function of sufficiently sensitive neurons are
affected by differences in sex steroid levels produced by
either the testes or ovaries during specific early windows
of sensitivity, as well as after sexual maturity is reached
[33]. A great deal of divergent development must resultfrom this interaction between genetic sex and the hor-
monal environment at the cellular level to produce a
sex-specific phenotype. Cellular behavior results from
the summation of all the molecular interactions occur-
ring within the cell, including such events as receptor-
ligand binding at the cell surface and the recruitment of
transcriptional machinery to regions of permissive chro-
matin structure. Arnold and Lusis highlight the utility of
modeling sex-specific cell function as the output of a
given network [34]. The nodes and connections com-
prising this network consist of gene products and their
interactions. The relative importance of a particular
node would be dependent on the number of other nodes
it interacts with and the strength of these interactions.
Some of these nodes would be sex-biased or sex-specific,
and the sum of the interactions between these nodes
and their connections, ‘the sexome’, would generate sex-
differences in the output of the network [34]. Taken to-
gether, the ability of miRs to target many transcripts and
modulate their expression with a high degree of control
and specificity suggests that they could serve as major
nodes within a cell network mediating sex-specific devel-
opmental processes and functions. Of course, for sex dif-
ferences to exist at the level of miRs, regulation of these
molecules by gonadal hormones or sex chromosomes
must exist.
Gonadal hormone regulation of miRs
Initial studies characterizing the impact of gonadal ster-
oids, including dihydrotestosterone, progesterone, and
estradiol on miR expression patterns have generally
involved the analyses of steady-state mature miR levels,
often in hormone-responsive tumor samples [35-42].
While appropriate first steps, these studies were gener-
ally unable to determine how the hormonal change
affected miR expression, and it has become clear that
these mechanisms are likely quite diverse.
Transcription effects of gonadal hormones. Gonadal
hormones acting through nuclear hormone receptors
(NHR) can have direct or indirect effects on gene ex-
pression. At the most basic level, ligand-bound NHRs
can directly bind to response elements in gene promo-
ters and recruit co-activators or co-repressors to alter
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miRs are themselves genes, they too can be regulated in
this manner. For example, estrogen receptor alpha (ERα)
binds regulatory regions upstream of both miR-21 and
-23a, stimulating their transcription in breast cancer
cells [42]. It is important to keep in mind that none of
these changes occur in isolation. NHRs and miRs are
part of the molecular network of the cell, and second-
ary/downstream events can be difficult to untangle from
the primary effects of the hormone once the system is
assayed [44]. For example, estradiol stimulates the ex-
pression of a cluster of 6 miRs as part of the primary
transcript pri-miR-17-92 in MCF-7 cells [45]. However,
there is no estrogen-receptor binding element (ERE) up-
stream of pri-miR-17-92. Instead, the induction of this
transcript is dependent on the activity of the ERα target
gene c-Myc. ERα activates c-Myc transcription by bind-
ing an upstream ERE, which in its role as a transcription
factor binds the miR-17-92 promoter and stimulates its
transcription [45]. Hence, similar to other genes, miRs
can be primary or secondary transcriptional targets of
gonadal hormones.
While it is always the case that the responses of cancer
cells may not reflect those of normal tissues, recent studies
of miRs in estrogen-responsive breast cancers have begun
to shed light on the dynamics of NHR activation of miR
genes. A 2011 study by Hah et al. provided a thorough ana-
lysis of the effects of sex steroid signaling on the transcrip-
tome [21]. This group performed a global run-on assay in
cells cultured with estradiol for acute time courses (10–
40 min). This technique allowed them to identify only those
primary transcripts that were being actively transcribed,
and so were likely primary targets of an estrogen receptor.
They identified 322 distinct pri-miRs in their dataset. Of
these, 37% were regulated by estradiol [21]. As they had
observed in protein-coding transcripts, a nearly equal num-
ber of miR-containing transcripts were induced as were
suppressed by estradiol [21]. Interestingly, they found that
nearly 20% of estradiol-regulated mRNAs that were pre-
dicted targets of miRs also identified as being regulated by
estrogen in this assay. Surprisingly, the direction of the es-
tradiol effect on a given miR did not predict whether its po-
tential mRNA target was correspondingly induced or
repressed. Thus, the interaction between estradiol-
responsive miRs and mRNA transcription may be coordi-
nated (miR suppressed while its target mRNA is induced)
or compensatory (both miR and its mRNA target induced).
These findings highlight the extent to which miR post-
transcriptional actions are integrated into a broader gene
regulatory machinery that is responsive to gonadal hor-
mones [21].
Post-transcriptional effects of gonadal hormones. In
addition to transcriptional effects, it is becoming clear that
some NHRs directly interact with components of the miRprocessing machinery, influencing miR processing [46].
Similar to mRNAs, miRs are regulated at seemingly every
step of their post-transcriptional processing, and instances
of estradiol acting at these points have been documented
[47,48]. Drosha and Dicer act as components of larger
complexes containing accessory proteins, often double-
stranded RNA-binding proteins, which can activate or re-
press the activity of these complexes. These actions may
be specific to individual miRs or families of miRs, or
broadly affect processing of all of the miRs expressed by
the cell [49-51]. Examples of hormonal regulation of miR
processing are growing in number. Yamagata et al. per-
formed a microarray analysis of uterine tissue samples
from ovariectomized female mice treated with estradiol,
and identified 39 miRs that were suppressed, though sur-
prisingly none that were induced [52]. A subset of these
miRs was further examined by northern blot analysis, and
while the reduced levels of mature miR were confirmed,
no effect of estradiol on precursor pri-miR levels was
observed [52]. These data suggested that estradiol was
affecting the post-transcriptional processing of these miRs.
Subsequent experiments demonstrated that ligand-bound
ERα inhibits the processing of many estrogen regulated
miRs by directly interacting with a portion of Drosha, ef-
fectively blocking its nuclease and RNA-binding activities.
This interaction was greatly strengthened by the presence
of two accessory proteins of the Drosha-containing micro-
processor complex, P68 and P72 [52]. Importantly, not all
of the miRs affected by estradiol required this P68/72-
dependent interaction, supporting a role for these and
other cofactors in providing specificity to the pools of
miRs regulated by a particular signal [53]. In addition,
Dicer and Argonaute gene expression is also responsive to
estrogenic signaling in breast cancer cell lines [42,54]. The
effect on Dicer expression was associated with ERα bind-
ing to an identified ERE approximately 40 kb downstream
of this gene [42,54]. In summay, these studies illustrate
that gonadal hormones can affect mature miR levels, both
directly and indirectly, through canonical NHR activity at
the transcriptional level, as well as by regulating miR post-
transcriptional processing, producing broad-reaching pro-
grammatic effects within cells and across tissues.
Sex-chromosomal regulation of miRs
Sex chromosomes typically generate sex-biased gene ex-
pression for two primary reasons: 1) Genes located on
the Y chromosome can only be expressed in males, and
2) Female cells contain two copies of the X chromo-
some, while males only have one. As the Y chromosome
contains no miR genes, hormone-independent mechan-
isms of sex-biased miR regulation are likely restricted to
those miRs that are encoded on the X chromosome or
are regulated by X-linked factors [55]. The mammalian
Figure 2 The neonatal brain displays extensive sex bias in miR
expression, which appears to result from both gonadal
hormone and sex chromosomal regulation. In our previous
studies, the expression of 240 miRs was assayed in postnatal day 2
whole brains from male and female mice. To determine the role of
organizational estradiol in the male brain to program the miR
environment, the aromatase inhibitor, formestane, was administered
to males at this time and brain tissue compared with that from
control males and females. Of these 240 miRs, 149 showed sex-
biased expression. These 149 miRs were then further subdivided by:
1) their apparent responsiveness to estradiol, where detected sex
differences were ameliorated by formestane treatment making them
regulated at some level by gonadal hormones, 2) as likely
attributable to X chromosome differences where females showed
higher levels (likely due to X gene dosage) and showed no changes
in males treated with formestane, or 3) uncategorized effect where
the pattern of change did not fit either model of gonadal hormone
effect or X-linkage. Of the 149 miRs with a basal sex difference,
changes related to estradiol occurred for almost half of these genes
(72 miRs), where aromatase inhibition dysmasculinized male
expression patterns to look more like that of the females. An effect
of sex chromosomes was estimated for 47 miRs, where aromatase
inhibition had no affect on male expression. Analysis criteria found
that neither regulatory mechanism could be attributed to 30 miRs.
(Adapted from Morgan and Bale, 2011 [11]).
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density of miRs on the X chromosome is approximately
two-fold higher than on autosomes in mice and humans
[56]. The X chromosome is also enriched for genes with
sex-biased expression involved in behavior and sexual
differentiation of many tissues, including the gonad
[57,58]. This is due to the fact that the X chromosome
experiences sex-specific selection pressure [59]. For ex-
ample, when dominant alleles that benefit females at the
cost of males are located on the X chromosome, they
are only exposed to negative selection pressure in males
one-third of the time, as one of the three states the X
chromosome can exist in [29]. In addition, the second X
chromosome in females masks male-benefiting alleles, as
in half of female cells the X chromosome containing the
deleterious allele will have been inactivated [29]. In
agreement with data suggesting that genes involved in
behavior and gonadal development are enriched on the
X chromosome, more X-linked miRs are expressed in
the gonad and brain than in nearly all other tissues [56].
Mammals compensate for a sex difference in X chromo-
some gene dosage by expressing the X-linked non-coding
RNA, Xist, from a locus on one of the X chromosomes,
termed the X-inactivation center. Xist spreads from this
locus, and through a still relatively unknown mechanism
directs the heterochromatinization and subsequent silen-
cing of gene expression from the Xist-expressing chromo-
some [60]. However, this silencing is not completely
penetrant. Approximately 25% of protein coding genes on
the inactive X chromosome are expressed to some degree
[61]. The expected result of this escape from inactivation
would be female-biased expression of a large number of X
chromosomal genes. Though no instances have yet been
reported, the general similarities between the transcrip-
tional regulation of protein- and miR-coding genes sug-
gests that a portion of X chromosomal miRs likely escape
inactivation as well. In fact, 86% of X-linked miRs do es-
cape meiotic sex chromosome inactivation, a mechanism
of gene dosage compensation resulting in the condensing
of the sex chromosomes during and after meiotic sperm-
atogenesis [62].
While little is known regarding X-linked miRs escaping
X-inactivation in mammals, Gunaratne et al. report an ex-
ample of biased expression of a sex-chromosome-linked
miR in the auditory forebrain of zebra finches in response
to birdsong, to which males and females have different be-
havioral responses [63]. miR-2954, located on the Z sex
chromosome, displayed sex-biased expression in response
to a novel birdsong. Unlike in male mammals, male zebra
finches are the homogametic sex, with a ZZ sex-
chromosome complement, and lack an efficient dosage
compensation mechanism [64]. Accordingly, miR-2954
was expressed at greater levels in the auditory forebrain of
males than females in response to exposure to a novelbirdsong [63]. Interestingly, the authors identified eight
predicted mRNA targets of miR-2954 that were also song-
responsive, suggesting that the sex-biased response of
miR-2954 may have a functional role in the sex-specific
responses of zebra finches to birdsong.
In our own studies, we have identified a group of miRs
with sex-biased expression in the neonatal brain that
appears to result from sex-chromosome effects (Figure 2)
[11]. Of 149 identified biased miRs in the neonatal
mouse brain, 47 appeared to be regulated through a sex
chromosome-dependent mechanism, in that the sex bias
in the expression of these miRs remained even after sex
differences in gonadal hormones were disrupted, though
a permanent organizational effect of previous hormone
differences cannot be excluded. Interestingly, only 7 of
these 47 miRs were located on the X chromosome, suggest-
ing that many of these genes may be regulated by X-linked
transcription factors [11]. However, of these 7 miRs, 6
Morgan and Bale Biology of Sex Differences 2012, 3:22 Page 7 of 9
http://www.bsd-journal.com/content/3/1/22were expressed at higher levels in females, as would be
expected if escaping X-inactivation. Considering these
findings, it is tempting to speculate that X-linked miRs
may play a particularly important role in establishing sex
differences.
miRs regulate cell processes necessary for sexual
differentiation of the brain
The first cellular mechanisms involved in sexual differen-
tiation of the brain to be identified were those respon-
sible for morphological differences in hypothalamic
nuclei in response to estradiol during the perinatal sensi-
tive period (as reviewed in [65]). While miRs had not
been previously implicated in these specific developmen-
tal processes, work in other fields has demonstrated that
miRs are important effectors in these same cellular
responses in other tissues. For example, the anteroventral
periventricular nucleus (AVPV) brain region is smaller in
males than in females [66]. This is, in part, due to the ac-
tivation of caspase-dependent apoptotic pathways by
perinatal estradiol [67]. Numerous miRs have been iden-
tified in processes involved in regulating apoptosis [68].
For example, sex differences in miR-23a expression and
its effect on one of its mRNA targets, X-linked inhibitor
of apoptosis (XIAP), are responsible for the sex-specific
activation of cell death in a model of cerebral ischemia
[8]. In addition, miR-101a and miR-199a are direct regu-
lators of COX-2, which is induced by estradiol in the
developing preoptic area, and is necessary to establish
sex differences in dendritic spine density in this region
[69,70]. Such examples demonstrate that miRs are often
regulators of processes similar to those occurring in cells
undergoing sexual differentiation in the developing brain,
and therefore may be the broad upstream target of estro-
gen’s effects during programming of the sexually di-
morphic brain. Recent data from our own lab support
the potent involvement of miRs in sexual differentiation
of the brain at a much broader level. By examining the
expression of nearly 250 of the most abundant rodent
miRs, we identified a robust sex-specific pattern of
miR expression in the neonatal brain where very dis-
tinct expression levels were found between males and
females on postnatal day 2 [11]. Interestingly, inhibit-
ing testosterone conversion to estradiol in male neo-
nates at this age with the aromatase inhibitor, formestane,
robustly disrupted the miR environment to the point that
hierarchical clustering was no longer able to differentiate
between female samples and males treated with formes-
tane, supporting a likely involvement of miRs in estrogen’s
effects [11]. It seems likely that the sex-specific pattern of
miR expression we observed is a read-out of sexual differ-
entiation at the cellular level, and that miRs play an import-
ant role in regulating these processes in sexually dimorphic
neuronal populations throughout the brain. Future studiesidentifying the specific mRNA targets of these miRs in
sexually dimorphic brain regions will likely yield new
insights into novel mechanisms through which the male
and female brain develops, and points of vulnerability to
insults during neurodevelopment.
Conclusions
NCBI's RefSeq project has annotated approximately
36,000 genes in both the human and mouse genome. Of
these, fewer then 500, or about 1%, are on the Y chromo-
some and not shared by males and females [71]. Thus,
the sex-biased expression of this shared genetic substrate
must be an integral component of the sexual differenti-
ation of a tissue. Evidence for this can be found in the
extent to which sex differences exist in the transcrip-
tomes of various tissues, with 55-72% of the active genes
in muscle, adipose, and liver tissue displaying sex-biased
expression [72]. The ability of miRs to regulate a large
number of genes with a high degree of specificity and
control makes them perfectly poised to play key roles in
sexually dimorphic programs of gene expression. Thus,
the study of miRs in sex-biased neurodevelopmental dis-
orders, though currently lacking, could provide novel
insight into pathophysiology and potential novel thera-
peutic targets in these diseases.
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